Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 98 Stomach Neoplasms 50 Rectal Neoplasms 45 Pancreatic Neoplasms 45 Colonic Neoplasms 36 Esophageal Neoplasms 34 Neoplasms 30 Neoplasm Metastasis 28 Squamous Cell Carcinoma of Head and Neck 27 Head and Neck Neoplasms 24 Breast Neoplasms 21 Adenocarcinoma Of Esophagus 20 Parkinson Disease 4, Autosomal Dominant Lewy Body 12 Adenocarcinoma 9 Anus Neoplasms 8 Esophageal Squamous Cell Carcinoma 7 Carcinoma, Squamous Cell 7 Carcinoma 7 Cholangiocarcinoma 6 Liver Neoplasms 5 Gallbladder Neoplasms 5 Bile Duct Neoplasms 5 Urinary Bladder Neoplasms 4 Pancreatic Adenocarcinoma 4 Gastrointestinal Neoplasms 4 Carcinoma, Hepatocellular 4 Skin Neoplasms 3 Sarcoma 3 Peritoneal Neoplasms 3 Laryngeal Neoplasms 3

Interventions

Nivolumab 5 Ipilimumab 3 relatlimab 1 daratumumab 1 Fluorouracil 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Various Advanced Cancer × Fluorouracil × Clear all

NCT03143153 2026-02-17

CheckMate 648

Bristol-Myers Squibb

Phase 3 Completed

970 enrolled 15 charts 1 FDA

Various Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡